Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_assertion type Assertion NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_head.
- NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_assertion wasGeneratedBy ECO_0000203 NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_provenance.
- NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_assertion wasDerivedFrom befree-2016 NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_provenance.
- NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_assertion SIO_000772 20683028 NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_provenance.
- NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_assertion evidence source_evidence_literature NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_provenance.
- NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_assertion description "[The combined effect of CYP1B1*3 polymorphism and NAT2 slow acetylator genotype contributed to an increased risk for breast cancer in patients in this study (p=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830527.RALeP5y4R2a0ciBBRI5JPYmlEDvk8qhLt7bKRarxHHmoA130_provenance.